Literature DB >> 21282812

Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan.

H Ishii, R Tazawa, C Kaneko, T Saraya, Y Inoue, E Hamano, Y Kogure, K Tomii, M Terada, T Takada, M Hojo, A Nishida, T Ichiwata, B C Trapnell, H Goto, K Nakata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21282812     DOI： 10.1183/09031936.00092910

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  22 in total

1.  T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung.

Authors:  Shoichi Iriguchi; Norihiro Kikuchi; Shin Kaneko; Emiko Noguchi; Yuko Morishima; Masashi Matsuyama; Keigyou Yoh; Satoru Takahashi; Hiromitsu Nakauchi; Yukio Ishii
Journal:  Blood       Date:  2014-10-27       Impact factor: 22.113

Review 2.  Pulmonary Alveolar Proteinosis Syndrome.

Authors:  Takuji Suzuki; Bruce C Trapnell
Journal:  Clin Chest Med       Date:  2016-06-17       Impact factor: 2.878

3.  Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function.

Authors:  Atsushi Nakamura; Risa Ebina-Shibuya; Ari Itoh-Nakadai; Akihiko Muto; Hiroki Shima; Daisuke Saigusa; Junken Aoki; Masahito Ebina; Toshihiro Nukiwa; Kazuhiko Igarashi
Journal:  J Exp Med       Date:  2013-10-14       Impact factor: 14.307

4.  Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient.

Authors:  Ashfaq Hasan; Raja Ram; Tln Swamy
Journal:  Lung India       Date:  2014-07

Review 5.  Secondary pulmonary alveolar proteinosis: a single-center retrospective study (a case series and literature review).

Authors:  Dongmei Zhang; Xinlun Tian; Ruie Feng; Xiaobei Guo; Peng Wang; Yusen Situ; Yi Xiao; Kai-Feng Xu
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317

Review 6.  GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm.

Authors:  Naoto Imoto; Nakashima Harunori; Katsuya Furukawa; Naoyuki Tange; Atsushi Murase; Masaya Hayakawa; Masatoshi Ichihara; Yosuke Iwata; Hiroshi Kosugi
Journal:  Intern Med       Date:  2017-02-15       Impact factor: 1.271

7.  Secondary pulmonary alveolar proteinosis treated by lung transplant: A case report.

Authors:  David Lawi; Estelle Dubruc; Michel Gonzalez; John-David Aubert; Paola M Soccal; Jean-Paul Janssens
Journal:  Respir Med Case Rep       Date:  2020-05-30

8.  Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis.

Authors:  Francesco Bonella; Shinichiro Ohshimo; Cai Miaotian; Matthias Griese; Josune Guzman; Ulrich Costabel
Journal:  Orphanet J Rare Dis       Date:  2013-04-04       Impact factor: 4.123

9.  Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study.

Authors:  Keiichi Akasaka; Takahiro Tanaka; Nobutaka Kitamura; Shinya Ohkouchi; Ryushi Tazawa; Toshinori Takada; Toshio Ichiwata; Etsuro Yamaguchi; Masaki Hirose; Toru Arai; Kentaro Nakano; Takahito Nei; Haruyuki Ishii; Tomohiro Handa; Yoshikazu Inoue; Koh Nakata
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

10.  Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.

Authors:  Haruyuki Ishii; John F Seymour; Ryushi Tazawa; Yoshikazu Inoue; Naoyuki Uchida; Aya Nishida; Yoshihito Kogure; Takeshi Saraya; Keisuke Tomii; Toshinori Takada; Yuko Itoh; Masayuki Hojo; Toshio Ichiwata; Hajime Goto; Koh Nakata
Journal:  BMC Pulm Med       Date:  2014-03-05       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.